Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children.

Abstract

Background: Asthma is a heterogeneous disease, characterized by chronic airway inflammation. Asthma exacerbations (AE) are episodes characterized by a progressive increase in symptoms of shortness of breath, cough, wheezing, or chest tightness with a decrease in lung function. There have been previous studies that examined the role of eosinophil-derived neurotoxin (EDN) in asthma, but there have been no studies of the role of EDN in children experiencing AE. Objective: In this study, we aimed to examine the association of EDN with lung function and prognosis in children admitted for severe AE. Methods: We enrolled 82 children who were admitted for severe AE at two different university hospitals in South Korea between January 2018 and December 2019. Blood tests, including white blood cell count, myeloperoxidase (MPO), total eosinophil count, EDN, C-reactive protein (CRP) level, and interleukin (IL) 4, IL-5, IL-10 values, and lung function were measured on admission and at discharge in each patient. Results: We observed significant decreases in the levels of MPO, EDN, CRP, and IL-4, with significant improvement in lung function after treatment. We then classified the subjects into two groups of different clinical phenotypes: eosinophilic asthma exacerbation (EAE) group and non-EAE group. EDN levels were higher and lung functions were lower in the EAE group. Also, we found that the EDN level was a significant biomarker useful for predicting the number of days for hospital stay. Conclusion: We found that EDN can act as a biomarker that reflects lung function, and that EDN could act as a prognostic biomarker, which demonstrated the complex role of EDN in children experiencing AE.

• Authors: Hwan Soo Kim, Hyeon-Jong Yang, Dae Jin Song, Yong Ju Lee, Dong In Suh, Jung Yeon Shim, Young Yoo, Chang Keun Kim, Young Min Ahn, Jin Tack Kim
• Journal: Allergy and asthma proceedings (Allergy Asthma Proc) Vol. 43 Issue 2 Pg. 133-139 (03 01 2022) ISSN: 1539-6304 [Electronic] United States
• PMID: 35317890 (Publication Type: Journal Article)

Chemical References

• Biomarkers
• Eosinophil-Derived Neurotoxin

Topics

• Asthma
• Biomarkers
• Eosinophil-Derived Neurotoxin (metabolism)
• Eosinophils (metabolism)
• Humans
• Pulmonary Eosinophilia